Teva Pharmaceutical Industries Newsroom

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $26

Futu NewsJan 13 20:31

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $28

Futu NewsDec 19, 2024 19:34

Teva Pharmaceutical Indus Analyst Ratings

BenzingaDec 18, 2024 23:06

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $28

Futu NewsDec 18, 2024 19:32

J.P. Morgan Maintains Teva Pharmaceutical Industries(TEVA.US) With Hold Rating

Futu NewsDec 18, 2024 10:32

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $25

Futu NewsDec 18, 2024 03:32

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsDec 6, 2024 01:35

UBS Upgrades Teva Pharmaceutical Industries(TEVA.US) to Buy Rating, Maintains Target Price $26

Futu NewsNov 11, 2024 17:33

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 11, 2024 16:32

UBS Downgrades Teva Pharmaceutical Industries(TEVA.US) to Hold Rating, Maintains Target Price $26

Futu NewsNov 8, 2024 21:32

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Futu NewsNov 7, 2024 20:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 7, 2024 16:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 6, 2024 16:33

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $25

Futu NewsOct 23, 2024 15:33

Teva Pharmaceutical Indus Analyst Ratings

BenzingaOct 21, 2024 22:38

J.P. Morgan Maintains Teva Pharmaceutical Industries(TEVA.US) With Hold Rating, Raises Target Price to $18

Futu NewsOct 21, 2024 20:36

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 16, 2024 16:32

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsOct 2, 2024 08:32

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24, 2024 18:32

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24, 2024 15:32